SOLIFENACIN MYLAN (Alphapharm Pty Ltd)
Product name
SOLIFENACIN MYLAN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
151 working days (255)
Active ingredients
solifenacin succinate
Registration type
New generic medicine
Indication
SOLIFENACIN MYLAN (tablet) is indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency or increased urinary frequency.